Is it appropriate to start a patient on Lantus (insulin glargine) 10 units once a day?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Starting a Patient on Lantus 10 Units Once Daily

Yes, starting a patient on Lantus (insulin glargine) 10 units once daily is an appropriate initial dosing strategy for most patients requiring basal insulin therapy.

Evidence-Based Rationale

According to the American Diabetes Association (ADA) guidelines, when initiating basal insulin therapy:

  • For insulin-naive patients, the recommended starting dose of insulin glargine is 0.1-0.2 units/kg/day or 10 units once daily 1
  • In hospitalized patients without previous insulin dosing, a reasonable starting point is 10 units of insulin glargine every 24 hours 2
  • The FDA-approved labeling for insulin glargine states that for patients with type 2 diabetes who are not currently treated with insulin, the recommended starting dosage is 0.2 units/kg or up to 10 units once daily 1

Dosing Considerations

Patient-Specific Factors

Consider adjusting the starting dose in these situations:

  • Lower starting dose (0.1-0.15 units/kg) for:

    • Patients with retinopathy (0.12 units/kg) 3
    • Patients with renal impairment (eGFR <60 mL/min/1.73m²) (0.114 units/kg) 3
    • Women (0.135 units/kg) 3
    • Elderly patients at higher risk of hypoglycemia 2
  • Higher starting dose (0.3-0.4 units/kg) may be reasonable for:

    • Patients with more severe hyperglycemia 2

Titration Protocol

After initiating Lantus at 10 units daily:

  • Monitor fasting blood glucose daily
  • Adjust dose every 3-7 days based on fasting glucose patterns:
    • FBG ≥180 mg/dL: Increase by 6-8 units
    • FBG 140-179 mg/dL: Increase by 4 units
    • FBG 120-139 mg/dL: Increase by 2 units
    • FBG 100-119 mg/dL: Maintain or increase by 0-2 units
    • FBG <100 mg/dL: Decrease by 2-4 units
    • Any hypoglycemia (<70 mg/dL): Decrease by 10-20% 4

Administration Guidance

  • Administer subcutaneously into the abdomen, thigh, or deltoid 1
  • Rotate injection sites within the same region to reduce risk of lipodystrophy 1
  • Can be administered at any time of day, but should be given at the same time every day for consistency 1, 5
  • For patients with nocturnal hyperglycemia, consider morning administration rather than evening 4

Common Pitfalls to Avoid

  1. Failure to titrate: The initial 10-unit dose is rarely the final effective dose. Regular titration based on blood glucose monitoring is essential for achieving glycemic targets 2.

  2. Overbasalization: Increasing basal insulin beyond 0.5 units/kg/day without adding prandial insulin may lead to overnight hypoglycemia without adequately controlling daytime glucose 2.

  3. Inadequate monitoring: During initiation and titration, daily self-monitoring of blood glucose is necessary 2.

  4. Mixing with other insulins: Lantus should not be mixed with other insulins in the same syringe 1.

  5. Discontinuing oral agents prematurely: When starting Lantus in type 2 diabetes, metformin should generally be continued 2.

Special Situations

  • Type 1 diabetes: Lantus must be used concomitantly with short-acting insulin 1
  • Hospitalized patients: A basal-plus approach (basal insulin with correctional doses) is preferred over sliding scale insulin alone 2
  • Patients on glucocorticoids: May require higher doses and different insulin regimens to manage steroid-induced hyperglycemia 2

Starting with 10 units of Lantus once daily provides a safe initial approach that can be titrated based on individual response, minimizing the risk of hypoglycemia while beginning to address hyperglycemia.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Managing Nocturnal Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Insulin Glargine: a review 8 years after its introduction.

Expert opinion on pharmacotherapy, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.